Airsculpt Technologies, Inc.

AIRS Nasdaq SEC CIK 1870940
Follow Airsculpt Technologies Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $31.9M −8.7% vs same quarter last year
Net income −$7.2M +24.6% vs same quarter last year
EPS, diluted −$0.10 +33.3% vs same quarter last year
Operating cash flow −$3.5M −1444.4% vs same quarter last year
Revenue by quarter
$39.2M
$39.4M
$44M
$35M
$33.4M
$39.4M
$42.9M
$31.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$100M$0$100M$200MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$151.8M−$11.7M
FY24$180.4M−$8M
FY23$195.9M−$4.2M
FY22$168.8M−$14.7M
FY21$133.3M-
FY20$62.8M$7.6M
FY19$41.2M−$2.2M
MarginsShare of revenue
  • Operating margin
  • Net margin
−10%0%10%20%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−7.6%−7.7%
FY24−0.9%−4.4%
FY235%−2.2%
FY22−2.7%−8.7%
FY2111.8%-
FY2016%12.1%
FY191.6%−5.4%
Free cash flowOperating cash flow minus capital expenditure
−$10M$0$10M$20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$692K
FY24−$2.7M
FY23$14M
FY22$11.5M
FY21$19.5M
FY20$10.3M
FY19$499K
Returned to shareholdersDividends paid and shares bought back
$0$10M$20M$30MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividends
FY25$0
FY24$252K
FY23$385K
FY22$23.2M
FY21$0
FY20$0
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Airsculpt Technologies
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAirsculpt TechnologiesHealthcare median
FY25−7.7%−30.6%
FY24−4.4%−47%
FY23−2.2%−58%
FY22−8.7%−80.4%
FY21-−71.9%
FY2012.1%−62.2%
FY19−5.4%−46.3%